SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-22-007407
Filing Date
2022-11-01
Accepted
2022-11-01 17:30:40
Documents
2
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1728
2 POWER OF ATTORNEY lgaultpoa.txt EX-24 1942
  Complete submission text file 0001562180-22-007407.txt   5022
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAGE THERAPEUTICS, INC. 245 FIRST STREET, SUITE 16 CAMBRIDGE MA 02142
Business Address
Gault Laura (Reporting) CIK: 0001951944 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36544 | Film No.: 221351634